Elimination of LC-MS/MS matrix effect due to phospholipids using specific solid-phase extraction elution conditions

Bioanalysis

Volumn 2, Issue 6, 2010, Pages 1011-1021

  Lahaie, Mathieu ^a   Mess, Jean Nicholas ^a   Furtado, Milton ^a   Garofolo, Fabio ^a  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ACETONITRILE; DICLOFENAC; ETODOLAC; LYSOPHOSPHATIDYLCHOLINE; METHANOL; PHOSPHATIDYLCHOLINE; POLYMER; SILANOL; SILICON DIOXIDE; WATER; ACETONITRILE DERIVATIVE; PHOSPHOLIPID;

ANALYTICAL ERROR; ANALYTICAL PARAMETERS; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DRUG DETERMINATION; DRUG STRUCTURE; ELUTION; HUMAN; HYDROPHOBICITY; INTERMETHOD COMPARISON; LIPID ANALYSIS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX EFFECT; QUALITY CONTROL; SOLID PHASE EXTRACTION; VALIDATION PROCESS; ARTIFACT; BLOOD; CHEMISTRY; ISOLATION AND PURIFICATION; METHODOLOGY; TANDEM MASS SPECTROMETRY;

ACETONITRILES; ARTIFACTS; CHROMATOGRAPHY, LIQUID; HUMANS; LYSOPHOSPHATIDYLCHOLINES; METHANOL; PHOSPHOLIPIDS; POLYMERS; SILICON DIOXIDE; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; WATER;

EID: 79951750007     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.10.65     Document Type: Article

References (18)

1. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 75(13), 3019-3030 (2003). (Pubitemid 36830428)
2. Bonfiglio R, King RC, Olah TV, Merkle K. The effect of sample preparation methods on the variability of the electrospray ionization response for model drug compounds. Rapid Commun. Mass. Spectrom. 13(12), 1175-1185 (1999) (Pubitemid 29285118)
3. Taylor PJ. Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. Clin. Biochem. 38(4), 328-334 (2005). (Pubitemid 40342863)
4. Van Eeckhaut A, Lanckmans K, Sarre S, Smolders I, Michotte Y. Validation of bioanalytical LC-MS/MS: evaluation of matrix effects. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877(23), 2198-2207 (2009).
5. Coté C, Bergeron A, Mess J-N, Furtado M, Garofolo M. Matrix effect elimination during LC-MS/MS bioanalytical method development. Bioanalysis 1(7), 1243-1257 (2009).
6. Jemal M, Ouyang Z, Xia YQ. Systematic LC-MS/MS bioanalytical method development that incorporates plasma phospholipids risk avoidance, usage of incurred sample and well thought-out chromatography. Biomed. Chromatogr. 24(1) 2-19 (2010).
7. Subbaiah PV. Determination and clinical significance of phospholipids. In:Handbook of Lipoprotein Testing (Second Edition). Rifai N, Warnick GR, Dominiczak MH (Eds).American Association for Clinical Chemistry Inc., Washington, DC, USA, 521-536 (2000).
8. Bennett PK, Van Horne KC. Identification of the major endogenous and persistent compounds in plasma, serum and tissue that cause matrix effects with electrospray LC/MS techniques. Presented at: American Association Pharmaceutical Scientists Annual Meeting and Exposition. Salt Lake City, UT, USA, 26-30 October 2003.
9. Xia YQ, Jemal M. Phospholipids in liquid chromatography/mass spectrometry bioanalysis: comparison of three tandem mass spectrometric techniques for monitoring plasma phospholipids, the effect of mobile phase composition on phospholipids elution and the association of phospholipids with matrix effects. Rapid Commun. Mass Spectrom. 23(14), 2125-2138 (2009).
10. Shen JX, Motyka RJ, Roach JP, Hayes RN. Minimization of ion suppression in LC-MS/MS analysis through the application of strong cation exchange solid-phase extraction (SCX-SPE).J. Pharm. Biomed. Anal. 37(2), 359-367 (2005). (Pubitemid 40222308)
11. Chambers E, Wagrowski-Diehl DM, Lu Z, Mazzeo JR. Systematic and comprehensive strategy for reducing matrix effects in LC-MS/MS analyses. J. Chromatogr. B Analyt Technol Biomed Life Sci. 852(1-2), 22-34 (2007). (Pubitemid 46830084)
12. Murphy RC. Mass Spectrometry of Phospholipids: Tables of Molecular and Product Ions. Illuminati Press, Denver, CO, USA (2002).
13. Neue UD. HPLC Columns: Theory, Technology, and Practice. Wiley-VCH, Inc, NY, USA, 164-216 (1997).
14. Snyder LR, Kirkland JJ, Glajch JL. Practical HPLC Method Development (Second Edition).John Wiley & Sons, Inc, NJ, USA, 178-182, 223, 224, 233-349, (1997).
15. Alpert AJ. Hydrophilic-interaction chromatography for the separation of peptides, nucleic acids and other polar compounds. J. Chromatogr. 499, 177-196 (1990). (Pubitemid 20044236)
16. Mess J-N, Cîté C, Bergeron A, Furtado M, Garofolo F. Selection of HILIC columns to handle matrix effect due to phospholipids. Bioanalysis 1(1), 57-62 (2009).
17. Simpson NJK. Solid-Phase Extraction, Principles, Technologies, and Applications. Marcel Dekker Inc., NY, USA, 227-237 (2000).
18. Bell DS, Jones AD. Solute attributes and molecular interactions contributing to 'U-shape' retention on a fluorinated high-performance liquid chromatography stationary phase. J. Chromatogr. A 1073(1-2), 99-109 (2005). (Pubitemid 40544481)